Company Information - Aesthetic Medical International Holdings Group Limited received a decision from the Nasdaq Hearings Panel for conditional continued listing[2] - The report is filed under Form 6-K for the month of April 2024[1] - The Chief Financial Officer of the company is Guanhua Wu[4] - The principal executive offices are located in Shenzhen, Guangdong Province, China[1] - The company is subject to the requirements of the Securities Exchange Act of 1934[3] - The commission file number for the company is 001-39088[1] - The address of the company is 1122 Nanshan Boulevard, Nanshan District, Shenzhen, Guangdong Province, China 518052[1] - The company has indicated its filing status under Form 20-F[1] Financial Performance - The report does not provide specific financial performance metrics or future outlook details[1] - There are no mentions of new products, technologies, market expansion, or acquisitions in the provided content[1]
Aesthetic Medical International Holdings(AIH) - 2023 Q4 - Annual Report